Peripheral T-cell activation in non-segmental vitiligo

Journal of Dermatology

Volumn 25, Issue 10, 1998, Pages 637-640

  Mahmoud, Fadia ^a,b   Abul, Habib ^b   Al Saleh, Qasem ^c   Haines, Donald ^d   Burleson, Joe ^d   Morgan, Gareth ^b  

^a Fac of All Hlth Sci and Nursing   (Kuwait)

^b KUWAIT UNIVERSITY   (Kuwait)

^c MINISTRY OF HEALTH   (Kuwait)

^d UNIVERSITY OF CONNECTICUT SCHOOL OF MEDICINE   (United States)

Author keywords

CD25; HLA DR; Peripheral blood; T lymphocytes; Vitiligo

Indexed keywords

CD20 ANTIGEN; CD4 ANTIGEN; CD45 ANTIGEN; CD8 ANTIGEN; FLUORESCEIN; HLA DR ANTIGEN; INTERLEUKIN 2 RECEPTOR; METHOXSALEN; MONOCLONAL ANTIBODY; PHYCOERYTHRIN;

ADULT; ANTIGEN EXPRESSION; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; FLOW CYTOMETRY; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNE STATUS; KUWAIT; MALE; PUVA; T LYMPHOCYTE ACTIVATION; T LYMPHOCYTE SUBPOPULATION; VITILIGO;

EID: 0031775739     PISSN: 03852407     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1346-8138.1998.tb02472.x     Document Type: Article

References (24)

1. Lerner AB: On the etiology of vitiligo, Am J Med, 51: 141-147, 1971.
2. Al-Abadie MS, Senior HJ, Bleehen SS, Gawkrodger DJ: Neuropeptide and neuronal marker studies in vitiligo, Br J Dermatol, 131: 160-165, 1994.
3. Slominski A, Paus R, Bomirski A: Hypothesis: Possible role for the melatonin receptor in vitiligo, Journal of the Royal Society of Medicine, 82: 539-541, 1989.
4. + T-cell subset and evidence for peripheral T-cell activation. Int J Dermatol, 31: 321-326, 1992.
5. Hertz KC, Kirkpatrick CH, Gazze LA, Katz SI: Autoimmune vitiligo: Detection of antibodies to melanin-producing cells, N Engl J Med, 297: 634-637, 1977.
6. Soubrian P, Benzaken S, Bellet C, et al: Vitiligo peripheral T cell subset imbalance as defined by monoclonal antibodies, Br J Dermatol, 113 (supple): 124-127, 1985.
7. Halder RM, Walter CS, Johnson BA, et al: Abberations in T lymphocytes and natural killer cells in vitiligo. A flow cytometry study, J Am Acad Dermatol, 14: 733-737, 1986.
8. Kao CH, Yu HS: Depletion and repopulation of Langeihans cells in nonsegmental type vitiligo, J Dermatol, 17: 287-296, 1990.
9. Hann SK, Park YK, Chung KY, Kim HI, Im S, Won JH: Peripheral blood lymphocyte imbalance in Koreans with active vitiligo, Int J Dermatol, 32: 286-289, 1993.
10. Grimes PE, Ghoneum M, Stockton T, Payne C, Kelly AP, Alfred L: T cell profiles in vitiligo, J Am Acad Dematol, 14: 196-201, 1986.
11. D'Amelio R, Frati C, Fattarossi A, Aiuti F: Peripheral T cell subset imbalance in patients with vitiligo and their apparently healthy first degree relatives, Ann Allergy, 65: 143-145, 1990.
12. Al-Fouzan A, Al-Arbash M, Fouad F, Kaaba SA, Mousa MA, Al-Harbi SA: Study of HLA class I/IL and T lymphocyte subsets in Kuwaiti vitiligo patients, Eur J Immunogenet, 22: 209-213, 1995.
13. Baumer FE, Frisch W, Milbradt R, Holzman H: Erhote Expression des OKM5-antigens auf Blut-monozyten bei vitiligo, Z Hautkr, 65: 914-919, 1990.
14. Mozzanica N, Frigerio U, Finzi AF, et al: T cell subpopulations in vitiligo: A chronobiologic study, J Am Acad Dermatol, 22: 223-230, 1990.
15. Stern RS, Nichols KT, Vakeva LH: Malignant melanoma in patients treated for psoriasis with methoxsalen (psoralen) and ultraviolet A radiation (PUVA), N Engl J Med, 336: 1041-1045, 1997.
16. Yoshiike T, Aikawa Y, Wongwaisayawan H, Ogawa H: HLA-DR antigen expression on peripheral T cell subsets in pityriasi rosea and herpes zoster, Dermatologica, 182: 160-163, 1991.
17. Imai R, Miura J, Takamori R, Ogawa H: Increased HLA-DR+ T lymphocyte population in peripheral blood of alopecia areata, Clin Exp Dermatol, 16: 176-181, 1991.
18. Al-Kassab AS, Raziuddin S: Immune activation and T cell subset abnormalities in circulation of patients with recently diagnosed type I diabetes mellitus, Clin Exp Immunol, 81: 267-271, 1990.
19. Durance RA: Myasthenia gravis, rheumatoid arthritis with vitiligo, and autoimmune hemolytic anemia, Proc R Soc Med, 64: 61-62, 1971.
20. Forestier JY, Ortonne JP, Thivolet J, Soutegraud P: Lupus erythemateux et vitiligo, Ann Dermatol Venereol, 108: 33-38, 1981.
21. Tomoda T, Taniguchi T, Kurashige T: Imbalance of the interleukin 2 system in children with IDDM, Diabetologia, 37: 476-482, 1994.
22. Gross A, Tapia FJ, Mosca W, et al: Mononuclear cell subpopulations and infiltrating lymphocytes in erythema dyschromicum perstans and vitiligo, Histol Histopathol, 2: 277-283, 1987.
23. Badri AM, Todd PM, Garioch JJ, Gudgeon JE, Stewart DG, Goudie RB: An immunohistological study of cutaneous lymphocytes in vitiligo, J Pathol, 170: 149-155, 1993.
24. Le Poole IC, van den Wijngaard RM, Westerhof W, Das PK: Presence of T cells and macrophages in inflammatory vitiligo skin parallels melanocyte disappearance, Am J Pathol, 148: 1219-1228, 1996.